Literature DB >> 23076353

Drug-dependence behaviour and outcome of medication-overuse headache after treatment.

Ilenia Corbelli1, Stefano Caproni, Paolo Eusebi, Paola Sarchielli.   

Abstract

This study aimed at determining the causes of failure of the different proposed strategies to ensure improvement of medication-overuse headache (MOH) patients, since they have not been investigated so far, especially with regard to aspects related to cognitive and behavioural aspects of symptomatic drugs overused by them. One hundred and twenty in-patients, 82 females (68.3 %), median age 49 (42-56) years, affected by MOH were admitted to the study and treated with abrupt discontinuation of the medication overused, a 6-day in-patient detoxification regimen and an immediate start of personalized prophylactic treatment, then followed for 1 year. Leeds Dependence Questionnaire (LDQ), among all the clinical variables, was administered at baseline and at 1-year follow-up visit to assess substance dependence. Of the 120 patients enrolled, 68 (56.7 %) were successfully detoxified (Responder-group), while 52 (43.3 %) were not (Non-Responder-group). At baseline, the mean LDQ total score was slightly higher in the Non-Responder group than in the Responder group (12.08 ± 2.14 vs. 11.94 ± 1.98). Although this difference was not significant at baseline (p > 0.05), the LDQ total score was significantly different (p < 0.001) at the 1-year follow-up visit between the responder group (7.8 ± 2.3) and the Non-Responder group (12.1 ± 2.1). Moreover, the pattern of the responses of the patients in the responder group differed from that of the Non-Responder-group in the items relating to the compulsion to start, compulsion to continue, primacy of effect, constancy of state and cognitive set. The results showed that patients of the Non-Responder group showed a drug dependence pattern similar to that previously described in addicts. Conversely, in patients who positively responded to the procedure, drug-abuse behaviour seemed to be a consequence of chronic headache, reflecting the need for daily analgesic use to cope with everyday life.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076353      PMCID: PMC3484260          DOI: 10.1007/s10194-012-0492-z

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  32 in total

Review 1.  Pathophysiology of medication-overuse headache: implications from animal studies.

Authors:  Saknan Bongsebandhu-phubhakdi; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Dependent behavior in patients with medication-overuse headache.

Authors:  Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Curr Pain Headache Rep       Date:  2012-02

3.  The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.

Authors:  S D Silberstein; J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; T J Steiner
Journal:  Cephalalgia       Date:  2005-06       Impact factor: 6.292

Review 4.  Neural mechanisms of addiction: the role of reward-related learning and memory.

Authors:  Steven E Hyman; Robert C Malenka; Eric J Nestler
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

Review 5.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  New appendix criteria open for a broader concept of chronic migraine.

Authors:  J Olesen; M-G Bousser; H-C Diener; D Dodick; M First; P J Goadsby; H Göbel; M J A Lainez; J W Lance; R B Lipton; G Nappi; F Sakai; J Schoenen; S D Silberstein; T J Steiner
Journal:  Cephalalgia       Date:  2006-06       Impact factor: 6.292

7.  Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package.

Authors:  D Raistrick; J Bradshaw; G Tober; J Weiner; J Allison; C Healey
Journal:  Addiction       Date:  1994-05       Impact factor: 6.526

Review 8.  A review of screening tools for psychiatric comorbidity in headache patients.

Authors:  Morris Maizels; Todd A Smitherman; Donald B Penzien
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

Review 9.  Medication-overuse headache: similarities with drug addiction.

Authors:  Paolo Calabresi; Letizia Maria Cupini
Journal:  Trends Pharmacol Sci       Date:  2005-02       Impact factor: 14.819

10.  The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients.

Authors:  A Ferrari; S Leone; R Tacchi; C Ferri; D Gallesi; D Giuggioli; A Bertolini
Journal:  Cephalalgia       Date:  2008-09-02       Impact factor: 6.292

View more
  5 in total

Review 1.  Barriers to Behavioral Treatment Adherence for Headache: An Examination of Attitudes, Beliefs, and Psychiatric Factors.

Authors:  Yuka Matsuzawa; Yuen Shan Christine Lee; Felicia Fraser; Donna Langenbahn; Amanda Shallcross; Scott Powers; Richard Lipton; Naomi Simon; Mia Minen
Journal:  Headache       Date:  2018-10-27       Impact factor: 5.887

2.  Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache.

Authors:  Sarah Cargnin; Michele Viana; Grazia Sances; Marika Bianchi; Natascia Ghiotto; Cristina Tassorelli; Giuseppe Nappi; Pier Luigi Canonico; Armando A Genazzani; Salvatore Terrazzino
Journal:  Eur J Clin Pharmacol       Date:  2014-08-07       Impact factor: 2.953

Review 3.  Medication-overuse headache: risk factors, pathophysiology and management.

Authors:  Hans-Christoph Diener; Dagny Holle; Kasja Solbach; Charly Gaul
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

4.  Migraine-specific quality of life questionnaire and relapse of medication overuse headache.

Authors:  Stefano Caproni; Elisa Bianchi; Letizia M Cupini; Ilenia Corbelli; Ettore Beghi; Paolo Calabresi; Paola Sarchielli
Journal:  BMC Neurol       Date:  2015-05-21       Impact factor: 2.474

5.  Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache.

Authors:  Stefano Caproni; Elisa Bianchi; Letizia M Cupini; Ilenia Corbelli; Ettore Beghi; Paolo Calabresi; Paola Sarchielli
Journal:  J Headache Pain       Date:  2014-12-15       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.